Skip to content
2000
Volume 28, Issue 2
  • ISSN: 1386-2073
  • E-ISSN: 1875-5402

Abstract

Background

Benzodiazepines (BZD) and Z-drugs are often prescribed for alleviating such symptoms and treating maternal psychiatric disorders and epilepsy. However, their use is limited due to the apprehensions and risks related to poor maternal and neonatal outcomes.

Objective

This meta-analysis evaluated the rationality and efficacy of using Benzodiazepines and Z-drugs for managing anxiety and depression in pregnant women.

Methods

The meta-analysis was based on a systematic review through keyword search utilizing Scopus, Pubmed, and Cochrane databases. One hundred three articles were deemed eligible, but only 21 articles were selected for the meta-analysis.

Results

The meta-analysis showed that despite the indication for anxiety and depression in pregnant women, the usage of BZD and Z-drugs was significantly low compared to other psychotropic medications, with no therapy or non-pharmacological interventions. Our study shows that, during the antenatal and postnatal period, women required more anti-depressants, anti-psychotics, and anxiolytic drugs.

Conclusion

Although BZDs and Z-drugs are effective in managing insomnia during peripartum and post-partum, they are either ineffective or contraindicated for managing anxiety and depression in pregnant women compared to anxiolytics and anti-depressants.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cchts/10.2174/0113862073278815240325045209
2024-03-28
2025-09-19

  • From This Site

    /content/journals/cchts/10.2174/0113862073278815240325045209
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Falah-HassaniK. ShiriR. DennisC.L. The prevalence of antenatal and postnatal co-morbid anxiety and depression: A meta-analysis.Psychol. Med.201747122041205310.1017/S0033291717000617 28414017
     [Google Scholar]
  2. Nielsen-ScottM. FellmethG. OpondoC. AlderdiceF. Prevalence of perinatal anxiety in low- and middle-income countries: A systematic review and meta-analysis.J. Affect. Disord.2022306717910.1016/j.jad.2022.03.032 35306121
     [Google Scholar]
  3. DennisC.L. Falah-HassaniK. ShiriR. Prevalence of antenatal and postnatal anxiety: Systematic review and meta-analysis.Br. J. Psychiatry2017210531532310.1192/bjp.bp.116.187179 28302701
     [Google Scholar]
  4. HendrickV. Psychiatric disorders in pregnancy and the postpartum: Principles and treatment.Totowa, NJHumana Press200610.1007/978‑1‑59745‑013‑3
     [Google Scholar]
  5. TsakiridisI. BousiV. DagklisT. SardeliC. NikolopoulouV. PapazisisG. Epidemiology of antenatal depression among women with high-risk pregnancies due to obstetric complications: A scoping review.Arch. Gynecol. Obstet.2019300484985910.1007/s00404‑019‑05270‑1 31422459
     [Google Scholar]
  6. El MarrounH. WhiteT. VerhulstF.C. TiemeierH. Maternal use of antidepressant or anxiolytic medication during pregnancy and childhood neurodevelopmental outcomes: A systematic review.Eur. Child Adolesc. Psychiatry2014231097399210.1007/s00787‑014‑0558‑3 24863148
     [Google Scholar]
  7. HandalM. EngelandA. RønningM. SkurtveitS. FuruK. Use of prescribed opioid analgesics and co-medication with benzodiazepines in women before, during, and after pregnancy: A population-based cohort study.Eur. J. Clin. Pharmacol.201167995396010.1007/s00228‑011‑1030‑7 21484468
     [Google Scholar]
  8. LarochelleM.R. ZhangF. Ross-DegnanD. WharamJ.F. Trends in opioid prescribing and co-prescribing of sedative hypnotics for acute and chronic musculoskeletal pain: 2001-2010.Pharmacoepidemiol. Drug Saf.201524888589210.1002/pds.3776 25906971
     [Google Scholar]
  9. RiskaB.S. SkurtveitS. FuruK. EngelandA. HandalM. Dispensing of benzodiazepines and benzodiazepine-related drugs to pregnant women: A population-based cohort study.Eur. J. Clin. Pharmacol.201470111367137410.1007/s00228‑014‑1744‑4 25204310
     [Google Scholar]
  10. BrandtJ. LeongC. Benzodiazepines and Z-drugs: An updated review of major adverse outcomes reported on in epidemiologic research.Drugs R D.201717449350710.1007/s40268‑017‑0207‑7 28865038
     [Google Scholar]
  11. HaasM. QuZ. KimT.H. VargasE. CampbellK. PetrouS. TanS.S. ReidC.A. HengJ. Perturbations in cortical development and neuronal network excitability arising from prenatal exposure to benzodiazepines in mice.Eur. J. Neurosci.201337101584159310.1111/ejn.12167 23451919
     [Google Scholar]
  12. BrownA.S. GyllenbergD. MalmH. McKeagueI.W. Hinkka-Yli-SalomäkiS. ArtamaM. GisslerM. Cheslack-PostavaK. WeissmanM.M. GingrichJ.A. SouranderA. Association of selective serotonin reuptake inhibitor exposure during pregnancy with speech, scholastic, and motor disorders in offspring.JAMA Psychiatry201673111163117010.1001/jamapsychiatry.2016.2594 27732704
     [Google Scholar]
  13. AskaaB. Jimenez-SolemE. Enghusen PoulsenH. Traerup AndersenJ. Maternal characteristics of women exposed to hypnotic benzodiazepine receptor agonist during pregnancy.Obstet. Gynecol. Int.201420141510.1155/2014/945621 24817891
     [Google Scholar]
  14. BaisT. Munk-OlsenV. BerginkX.L. Prescription patterns of benzodiazepine and benzodiazepine-related drugs in the peripartum period: A population-based study.Psychiatry Res.202028811299310.1016/j.psychres.2020.112993
     [Google Scholar]
  15. MitchellA.A. GilboaS.M. WerlerM.M. KelleyK.E. LouikC. Hernández-DíazS. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008.Am. J. Obstet. Gynecol.2011205151.e151.e810.1016/j.ajog.2011.02.029 21514558
     [Google Scholar]
  16. HanleyG.E. MillerT. MintzesB. A cohort study of psychotropic prescription drug use in pregnancy in British Columbia, Canada from 1997 to 2010.J. Womens Health 202029101339134910.1089/jwh.2019.8199 32176573
     [Google Scholar]
  17. HanleyG.E. MintzesB. Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance.BMC Pregnancy Childbirth201414124210.1186/1471‑2393‑14‑242 25048574
     [Google Scholar]
  18. WürtzA.M.L. Høstrup VestergaardC. RytterD. SørensenM.J. ChristensenJ. VestergaardM. BechB.H. Prenatal exposure to antipsychotic medication and use of primary health care system in childhood: A population-based cohort study in Denmark.Clin. Epidemiol.2017965766610.2147/CLEP.S145524 29238228
     [Google Scholar]
  19. PalmstenK. Hernández-DíazS. ChambersC.D. MogunH. LaiS. GilmerT.P. HuybrechtsK.F. The most commonly dispensed prescription medications among pregnant women enrolled in the U.S. medicaid program.Obstet. Gynecol.2015126346547310.1097/AOG.0000000000000982 26244530
     [Google Scholar]
  20. YonkersK.A. Gilstad-HaydenK. ForrayA. LipkindH.S. Association of panic disorder, generalized anxiety disorder, and benzodiazepine treatment during pregnancy with risk of adverse birth outcomes.JAMA Psychiatry201774111145115210.1001/jamapsychiatry.2017.2733 28903165
     [Google Scholar]
  21. QatoD.M. GandhiA.B. Opioid and benzodiazepine dispensing and co-dispensing patterns among commercially insured pregnant women in the United States, 2007–2015.BMC Pregnancy Childbirth202121135010.1186/s12884‑021‑03787‑5 33941106
     [Google Scholar]
  22. BlotièreP.O. MirandaS. WeillA. MikaeloffY. PeyreH. RamusF. MahmoudZ. CosteJ. Dray-SpiraR. Risk of early neurodevelopmental outcomes associated with prenatal exposure to the antiepileptic drugs most commonly used during pregnancy: A French nationwide population-based cohort study.BMJ Open2020106e03482910.1136/bmjopen‑2019‑034829 32513880
     [Google Scholar]
  23. BrandlistuenR.E. YstromE. Hernandez-DiazS. SkurtveitS. SelmerR. HandalM. NordengH. Association of prenatal exposure to benzodiazepines and child internalizing problems: A sibling-controlled cohort study.PLoS One2017127e018104210.1371/journal.pone.0181042 28746341
     [Google Scholar]
  24. LaegreidL. HagbergG. LundbergA. Neurodevelopment in late infancy after prenatal exposure to benzodiazepines--a prospective study.Neuropediatrics1992232606710.1055/s‑2008‑1071314 1351263
     [Google Scholar]
  25. LupattelliA. ChambersC.D. BandoliG. HandalM. SkurtveitS. NordengH. Association of maternal use of benzodiazepines and Z-hypnotics during pregnancy with motor and communication skills and attention-deficit/hyperactivity disorder symptoms in preschoolers.JAMA Netw. Open201924e19143510.1001/jamanetworkopen.2019.1435 30951155
     [Google Scholar]
  26. ReebyeP.N. NgT.W.C. MisriS. StikarovskaI. Affect expression and self-regulation capacities of infants exposed in utero to psychotropics.Front. Psychiatry201231110.3389/fpsyt.2012.00011 22403552
     [Google Scholar]
  27. ElkjærL.S. BechB.H. SunY. LaursenT.M. ChristensenJ. Association between prenatal valproate exposure and performance on standardized language and mathematics tests in school-aged children.JAMA Neurol.201875666367110.1001/jamaneurol.2017.5035 29459981
     [Google Scholar]
  28. FigueroaR. Use of antidepressants during pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring.J. Dev. Behav. Pediatr.201031864164810.1097/DBP.0b013e3181e5ac93 20613624
     [Google Scholar]
  29. MattsonSN CalarcoKE ChambersCD Interaction of maternal smoking and other in-pregnancy exposures: Analytic considerations.Special Issue: Festschrift in honour of Peter Fried2002243359367
     [Google Scholar]
  30. MisriS. ReebyeP. KendrickK. CarterD. RyanD. GrunauR.E. OberlanderT.F. Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications.Am. J. Psychiatry200616361026103210.1176/ajp.2006.163.6.1026 16741203
     [Google Scholar]
  31. MortensenJ.T. OlsenJ. LarsenH. BendsenJ. ObelC. SørensenH.T. Psychomotor development in children exposed in utero to benzodiazepines, antidepressants, neuroleptics, and anti-epileptics.Eur. J. Epidemiol.200218876977110.1023/A:1025306304635 12974552
     [Google Scholar]
  32. OdsbuI. SkurtveitS. SelmerR. RothC. Hernandez-DiazS. HandalM. Prenatal exposure to anxiolytics and hypnotics and language competence at 3 years of age.Eur. J. Clin. Pharmacol.201571328329110.1007/s00228‑014‑1797‑4 25547568
     [Google Scholar]
  33. ReebyeP.N. MorisonS.J. PanikkarH. MisriS. GrunauR.E. Affect expression in prenatally psychotropic exposed and nonexposed mother–infant dyads.Infant Ment. Health J.200223440341610.1002/imhj.10025
     [Google Scholar]
  34. SchechterJ.C. BrennanP.A. SmithA.K. StoweZ.N. NewportD.J. JohnsonK.C. Maternal prenatal psychological distress and preschool cognitive functioning: the protective role of positive parental engagement.J. Abnorm. Child Psychol.201745224926010.1007/s10802‑016‑0161‑9 27150387
     [Google Scholar]
  35. Radojčić, M.R.; El Marroun, H.; Miljković, B.; Stricker, B.H.C.; Jaddoe, V.W.V.; Verhulst, F.C.; White, T.; Tiemeier, H. Prenatal exposure to anxiolytic and hypnotic medication in relation to behavioral problems in childhood: A population-based cohort study.Neurotoxicol. Teratol.201761586510.1016/j.ntt.2017.02.005 28259732
     [Google Scholar]
  36. WangX. ZhangT. EkhedenI. ChangZ. HellnerC. Jan Hasselström; Jayaram-Lindström, N.; M D’Onofrio, B.; Larsson, H.; Mataix-Cols, D.; Sidorchuk, A. Prenatal exposure to benzodiazepines and Z-drugs in humans and risk of adverse neurodevelopmental outcomes in offspring: A systematic review.Neurosci. Biobehav. Rev.202213710464710.1016/j.neubiorev.2022.104647 35367514
     [Google Scholar]
  37. SinghR.K. PrasadD.N. BhardwajT.R. Design, synthesis and antiproliferative activity of benzodiazepine-mustard conjugates as potential brain antitumour agents.J. Saudi Chem. Soc.201721S1S86S9310.1016/j.jscs.2013.10.004
     [Google Scholar]
  38. SinghR.K. PrasadD.N. BhardwajT.R. Design, synthesis and evaluation of aminobenzophenone derivatives containing nitrogen mustard moiety as potential CNS antitumour agents.Med. Chem. Res.201322125901591110.1007/s00044‑013‑0582‑8
     [Google Scholar]
  39. TinkerS.C. ReefhuisJ. BitskoR.H. GilboaS.M. MitchellA.A. TranE.L. WerlerM.M. BroussardC.S. Use of benzodiazepine medications during pregnancy and potential risk for birth defects, national birth defects prevention study, 1997–2011.Birth Defects Res.20191111061362010.1002/bdr2.1497 30891943
     [Google Scholar]
  40. GriffinC.E.III KayeA.M. BuenoF.R. KayeA.D. Benzodiazepine pharmacology and central nervous system-mediated effects.Ochsner J.2013132214223 23789008
     [Google Scholar]
  41. LarsenE.R. DamkierP. PedersenL.H. Fenger-GronJ. MikkelsenR.L. NielsenR.E. LindeV.J. KnudsenH.E.D. SkaarupL. VidebechP. Use of psychotropic drugs during pregnancy and breast-feeding.Acta Psychiatr. Scand.2015132S44512810.1111/acps.12479 26344706
     [Google Scholar]
  42. FreemanM.P. Góez-MogollónL. McInerneyK.A. DaviesA.C. ChurchT.R. SosinskyA.Z. NoeO.B. VigueraA.C. CohenL.S. Obstetrical and neonatal outcomes after benzodiazepine exposure during pregnancy: Results from a prospective registry of women with psychiatric disorders.Gen. Hosp. Psychiatry201853737910.1016/j.genhosppsych.2018.05.010 29958100
     [Google Scholar]
  43. OgawaY. TakeshimaN. FurukawaT.A. Maternal exposure to benzodiazepine and risk of preterm birth and low birth weight: A case-control study using a claims database in Japan.Asia-Pac. Psychiatry2018103e1230910.1111/appy.12309 29314716
     [Google Scholar]
  44. BaisB. MolenaarN.M. BijmaH.H. HoogendijkW.J.G. MulderC.L. LuikA.I. Lambregtse-van den BergM.P. KampermanA.M. Prevalence of benzodiazepines and benzodiazepine-related drugs exposure before, during and after pregnancy: A systematic review and meta-analysis.J. Affect. Disord.2020269182710.1016/j.jad.2020.03.014 32217339
     [Google Scholar]
  45. BonacinaG. CarolloA. EspositoG. The genetic side of the mood: A scientometric review of the genetic basis of mood disorders.Genes 202314235210.3390/genes14020352 36833279
     [Google Scholar]
  46. KõksS. NikopensiusT. KoidoK. MaronE. AltmäeS. HeinasteE. VabritK. TammekiviV. HallastP. KurgA. ShlikJ. VasarV. MetspaluA. VasarE. Analysis of SNP profiles in patients with major depressive disorder.Int. J. Neuropsychopharmacol.20069216717410.1017/S1461145705005468 15927089
     [Google Scholar]
  47. KoidoK. TraksT. BalõtševR. EllerT. MustA. KoksS. MaronE. TõruI. ShlikJ. VasarV. VasarE. Associations between LSAMP gene polymorphisms and major depressive disorder and panic disorder.Transl. Psychiatry201228e15210.1038/tp.2012.74 22892717
     [Google Scholar]
  48. RaudS. InnosJ. AbramovU. ReimetsA. KõksS. SoosaarA. MatsuiT. VasarE. Targeted invalidation of CCK2 receptor gene induces anxiolytic-like action in light–dark exploration, but not in fear conditioning test.Psychopharmacology 2005181234735710.1007/s00213‑005‑2255‑x 15830228
     [Google Scholar]
  49. NelovkovA. AredaT. InnosJ. KõksS. VasarE. Rats displaying distinct exploratory activity also have different expression patterns of γ-aminobutyric acid- and cholecystokinin-related genes in brain regions.Brain Res.200611001213110.1016/j.brainres.2006.05.007 16769038
     [Google Scholar]
  50. IoannidisJ.P.A. PatsopoulosN.A. EvangelouE. Uncertainty in heterogeneity estimates in meta-analyses.BMJ2007335762691491610.1136/bmj.39343.408449.80 17974687
     [Google Scholar]
/content/journals/cchts/10.2174/0113862073278815240325045209
Loading
Effect of Benzodiazepines and Z-Drug Medications During Antenatal and Postnatal Depression and Anxiety: A Systematic Review and Meta-Analysis
Comb Chem High Throughput Screen 28, 239 (2025); https://doi.org/10.2174/0113862073278815240325045209
/content/journals/cchts/10.2174/0113862073278815240325045209
/content/journals/cchts/10.2174/0113862073278815240325045209
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Research Article
Keyword(s): Antenatal; anxiety; benzodiazepines; depression; postnatal; Z-drugs

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test